Viewing Study NCT00221312


Ignite Creation Date: 2025-12-26 @ 11:07 AM
Ignite Modification Date: 2025-12-29 @ 4:22 AM
Study NCT ID: NCT00221312
Status: COMPLETED
Last Update Posted: 2008-05-08
First Post: 2005-09-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss
Sponsor: University of California, San Francisco
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module